These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6422042)

  • 21. Effect of alrestatin on arginine-induced secretion of glucagon and insulin in the rat.
    Lippmann W; Kobric M
    Horm Metab Res; 1978 Jul; 10(4):280-2. PubMed ID: 98419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of tolrestat, a novel aldose reductase inhibitor, in serum and tissues.
    Hicks DR; Kraml M
    Ther Drug Monit; 1984; 6(3):328-33. PubMed ID: 6438835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of aldose reductase by 3',4'-dihydroxyflavones.
    Okuda J; Miwa I; Inagaki K; Horie T; Nakayama M
    Chem Pharm Bull (Tokyo); 1984 Feb; 32(2):767-72. PubMed ID: 6428761
    [No Abstract]   [Full Text] [Related]  

  • 24. Novel spirosuccinimide aldose reductase inhibitors derived from isoquinoline-1,3-diones: 2-[(4-bromo-2-fluorophenyl)methyl]-6- fluorospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrone and congeners. 1.
    Malamas MS; Hohman TC; Millen J
    J Med Chem; 1994 Jun; 37(13):2043-58. PubMed ID: 8027986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altering the course of cataracts in diabetic rats.
    Fukushi S; Merola LO; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1980 Mar; 19(3):313-5. PubMed ID: 6766909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in the susceptibility of various aldose reductases to inhibition. II.
    Kador PF; Kinoshita JH; Tung WH; Chylack LT
    Invest Ophthalmol Vis Sci; 1980 Aug; 19(8):980-2. PubMed ID: 6773903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition kinetics of human kidney aldose and aldehyde reductases by aldose reductase inhibitors.
    Bhatnagar A; Liu SQ; Das B; Ansari NH; Srivastava SK
    Biochem Pharmacol; 1990 Mar; 39(6):1115-24. PubMed ID: 2157439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of lens-aldose reductase activity by brazilin and haematoxylin.
    Moon CK; Yun YP; Lee JH; Wagner H; Shin YS
    Planta Med; 1985 Feb; (1):66-7. PubMed ID: 3925476
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibition of aldehyde reductase by aldose reductase inhibitors.
    Sato S; Kador PF
    Biochem Pharmacol; 1990 Sep; 40(5):1033-42. PubMed ID: 2117925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of Alrestatin, an aldose reductase inhibitor, in human diabetic and nondiabetic lenses.
    Chylack LT; Henriques HF; Cheng HM; Tung WH
    Ophthalmology; 1979 Sep; 86(9):1579-85. PubMed ID: 121768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-performance liquid chromatographic analysis of glucose, fructose, sorbitol and low levels of the aldose reductase inhibitor sorbinil in human lens and plasma.
    Lloyd P; Crabbe MJ
    J Chromatogr; 1985 Oct; 343(2):402-6. PubMed ID: 3934205
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhibition of aldose reductases from rat and bovine lenses by hydantoin derivatives.
    Inagaki K; Miwa I; Yashiro T; Okuda J
    Chem Pharm Bull (Tokyo); 1982 Sep; 30(9):3244-54. PubMed ID: 6816474
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of aldose reductase and its inhibition on sugar cataract formation.
    Kador PF; Akagi Y; Kinoshita JH
    Metabolism; 1986 Apr; 35(4 Suppl 1):15-9. PubMed ID: 3083204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of lens aldose reductase by Labiatae flavonoids.
    Tomás-Barberán FA; López-Gómez C; Villar A; Tomás-Lorente F
    Planta Med; 1986 Jun; (3):239-40. PubMed ID: 3092256
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibition of erythrocyte anion exchange by tolrestat, an inhibitor of aldose reductase.
    Gunn RB; Gunn HB
    Metabolism; 1989 Aug; 38(8):801-4. PubMed ID: 2503683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Inhibition of aldose reductase from the rat lens by flavonoids].
    Xie MZ; Shen ZF
    Yao Xue Xue Bao; 1986 Oct; 21(10):721-4. PubMed ID: 3107341
    [No Abstract]   [Full Text] [Related]  

  • 37. Irreversible aldose reductase inhibitors.
    Kador PF; Gurley RC; Ares JJ; Miller DD
    Prog Clin Biol Res; 1987; 232():353-65. PubMed ID: 3112788
    [No Abstract]   [Full Text] [Related]  

  • 38. The utilization of 13C and 31P nuclear magnetic resonance spectroscopy in the study of the sorbitol pathway and aldose reductase inhibition in intact rabbit lenses.
    Williams WF; Odom JD
    Exp Eye Res; 1987 Jun; 44(6):717-30. PubMed ID: 3115803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diabetic changes in pupillary reaction and iridal pathology. No. 1. The role of aldose reductase to the delayed pupillary reaction in galactose-fed rats].
    Terubayashi H; Akagi Y; Kador PF; Kinoshita JH
    Nippon Ganka Gakkai Zasshi; 1988 Mar; 92(3):484-8. PubMed ID: 3137794
    [No Abstract]   [Full Text] [Related]  

  • 40. [Aldose reductase and its inhibitors. Current data].
    Bordat B; Misse P; Bourgeoiset C; Navarre L
    Bull Soc Ophtalmol Fr; 1989; 89(6-7):885-9. PubMed ID: 2514048
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.